Biomarin Pharmaceutical (BMRN) Construction in Progress (2010 - 2013)

Biomarin Pharmaceutical (BMRN) has 4 years of Construction in Progress data on file, last reported at $77.2 million in Q4 2013.

• Quarterly Construction in Progress rose 20.08% year-over-year to $77.2 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $77.2 million (up 20.08% YoY) and the FY2013 annual result came in at $77.2 million, up 20.08% from the prior year.
• Construction in Progress improved to $77.2 million in Q4 2013, from $64.8 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $77.2 million in Q4 2013 to a low of $14.7 million in Q4 2010.
• A 4-year average of $58.1 million and a median of $63.0 million in 2012 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2011 — Construction in Progress jumped 265.84% — and 2013, when it gained 10.66%.
• Tracing BMRN's Construction in Progress over 4 years: stood at $14.7 million in 2010, then jumped by 265.84% to $53.9 million in 2011, then climbed by 19.33% to $64.3 million in 2012, then rose by 20.08% to $77.2 million in 2013.
• The last three Construction in Progress figures came in at $77.2 million (Q4 2013), $64.8 million (Q3 2013), and $68.2 million (Q2 2013), per Business Quant data.